ASRT vs CLOV
Assertio Therapeutics Inc (ASRT) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ASRT currently screens at market cap $151.5M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ASRT and CLOV stock pages for the full models.
Not investment advice.